Burcon Nutrascience (TSE:BU) has released an update.
Burcon NutraScience Corporation has reported a positive fiscal year 2024, highlighting a strategic turnaround with the successful scale-up of commercial production, notably of the world’s first 95% hempseed protein isolate. The company has exceeded initial expectations for customer demand and has entered into significant agreements, including production partnerships and co-investments, signaling robust growth potential in the plant-based protein market. With initial commercial sales underway and an expansion into the canola protein market, Burcon is poised to capitalize on its innovative offerings in a burgeoning $40 billion market.
For further insights into TSE:BU stock, check out TipRanks’ Stock Analysis page.
